loading
Schlusskurs vom Vortag:
$1.71
Offen:
$1.73
24-Stunden-Volumen:
37,852
Relative Volume:
0.10
Marktkapitalisierung:
$52.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.94M
KGV:
-1.25
EPS:
-1.38
Netto-Cashflow:
$-15.79M
1W Leistung:
-3.09%
1M Leistung:
-0.86%
6M Leistung:
-9.21%
1J Leistung:
-51.13%
1-Tages-Spanne:
Value
$1.7109
$1.735
1-Wochen-Bereich:
Value
$1.64
$1.80
52-Wochen-Spanne:
Value
$1.40
$3.742

MAIA Biotechnology Inc Stock (MAIA) Company Profile

Name
Firmenname
MAIA Biotechnology Inc
Name
Telefon
312 416 8592
Name
Adresse
444 West Lake Street, Suite 1700, Chicago
Name
Mitarbeiter
18
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-24
Name
Neueste SEC-Einreichungen
Name
MAIA's Discussions on Twitter

Vergleichen Sie MAIA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MAIA
MAIA Biotechnology Inc
1.725 51.39M 0 -25.94M -15.79M -1.38
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
473.86 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
571.30 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.26 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
581.51 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.26 31.99B 3.81B -644.79M -669.77M -6.24

MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten

pulisher
Jul 23, 2025

MAIA Biotechnology Inc. Stock Analysis and ForecastDynamic profit opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is MAIA Biotechnology Inc. a good long term investmentBreakout stock performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives MAIA Biotechnology Inc. stock priceFree Stock Selection - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about MAIA Biotechnology Inc. stockSuperior investment outcomes - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 21, 2025

MAIA Biotechnology’s 41% decline validates InvestingPro’s overvalued call By Investing.com - Investing.com

Jul 21, 2025
pulisher
Jul 19, 2025

Is MAIA Biotechnology Inc. stock a growth or value playMomentum Swing Watchlist - beatles.ru

Jul 19, 2025
pulisher
Jul 18, 2025

When is the best time to buy MAIA Biotechnology Inc. stockPro Trader Stock Focus - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Maia Biotechnology stock soars after publishing promising preclinical data - Investing.com

Jul 18, 2025
pulisher
Jul 17, 2025

MAIA Biotechnology Publishes Promising Preclinical Cancer Data - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

MAIA Biotechnology publishes preclinical data on cancer drug candidates By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Maia Biotechnology stock soars after publishing promising preclinical data By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

MAIA Biotechnology publishes preclinical data on cancer drug candidates - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer Therapy - Business Wire

Jul 17, 2025
pulisher
Jul 15, 2025

Why MAIA Biotechnology Inc. stock attracts strong analyst attentionFree Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How MAIA Biotechnology Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes MAIA Biotechnology Inc. stock price move sharplySteady Profit Stock Forecasts - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

MAIA Biotechnology doses first patient in expansion of Phase II lung cancer trial - Yahoo Finance

Jul 10, 2025
pulisher
Jul 10, 2025

MAIA Biotechnology doses first patient in Taiwan for NSCLC trial By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer - BioSpace

Jul 09, 2025
pulisher
Jul 09, 2025

MAIA Biotechnology Begins Phase 2 Trial Expansion - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Up 0.5% – Still a Buy? - Defense World

Jul 09, 2025
pulisher
Jul 04, 2025

Public market insider buying at Canaccord Genuity Group (CF) - The Globe and Mail

Jul 04, 2025
pulisher
Jul 01, 2025

MAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 Congress - BioSpace

Jul 01, 2025
pulisher
Jun 26, 2025

Maia Biotechnology enters stock purchase agreement for up to $587,905 with Prevail Partners - Investing.com

Jun 26, 2025

Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.55
price up icon 3.06%
$36.26
price up icon 0.64%
$102.96
price down icon 0.51%
$27.70
price down icon 0.89%
$114.09
price down icon 0.58%
biotechnology ONC
$294.60
price down icon 0.15%
Kapitalisierung:     |  Volumen (24h):